Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

DFTX holding history

Definium Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DFTX overviewAll 13F holders of DFTXFull Q2 2026 holdings

Shares (Q2 2026)
499,467
Value
$23.5M
% of portfolio
<0.1%
Quarters held
21
Since Q2 2021
Holdings of DFTX by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026499,467$23.5M<0.1%+5,490+1.1%AddedHolders
Q1 2026493,977$9.34M<0.1%−189,825−27.8%ReducedHolders
Q4 2025683,802$9.16M<0.1%+131,993+23.9%AddedHolders
Q3 2025551,809$6.51M<0.1%+37,364+7.3%AddedHolders
Q2 2025514,445$3.34M<0.1%+406,419+376.2%AddedHolders
Q1 2025108,026$632.0K<0.1%−6,412−5.6%ReducedHolders
Q4 2024114,438$796.5K<0.1%−13,860−10.8%ReducedHolders
Q3 2024128,298$730.0K<0.1%+71,810+127.1%AddedHolders
Q2 202456,488$407.3K<0.1%+32,104+131.7%AddedHolders
Q1 202424,384$229.2K<0.1%+23,981+5,950.6%AddedHolders
Q4 2023403$1.48K<0.1%−4,111−91.1%ReducedHolders
Q3 20234,514$14.1K<0.1%+3,762+500.3%AddedHolders
Q2 2023752$2.68K<0.1%−9,050−92.3%ReducedHolders
Q1 20239,802$31.1K<0.1%−5,734−36.9%ReducedHolders
Q4 202215,536$34.2K<0.1%−6,711−30.2%ReducedHolders
Q3 202222,247$78.0K<0.1%+20,451+1,138.4%AddedConverted for a 1-for-15 splitHolders
Q2 202226,946$17.0K<0.1%+5,615+26.3%AddedHolders
Q1 202221,331$24.0K<0.1%−85,500−80.0%ReducedHolders
Q4 2021106,831$147.0K<0.1%+105,784+10,103.5%AddedHolders
Q3 20211,047$2.00K<0.1%+791+309.0%AddedHolders
Q2 2021256$1.00K<0.1%+256NewHolders